LDTs Rule Update: More Support for Legal Challenges Against FDA
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
News
The latest regulatory, legal, compliance, and technology news for labs and pathology practices.
Subscribe today for access to
Articles and Reports
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
CMS Slated to Close Change Healthcare Payment Program
Program meant to ease cash flow disruptions experienced by some Medicare providers and suppliers due to the cyberattack will conclude in mid-July
Thermo and Symphogen Aim to Boost Biopharma Discovery
SAN JOSE, CA —...
COVID-19 Infection Detected in Breath Tests
Traces of the...
OIG Gives Green Light to Employee Tuition Reimbursement Benefits
Could paying the tuition costs of employees seeking certification put you at risk of violating the AKS?
Hematology Testing Solution Company Earns Key Grant
YOKNEAM ILLIT,...
Helping Patients with Cancer Better Manage Ocular Toxicities
CAMBRIDGE, MA...
